Table 1.
Serum level of T3 in the TBT-treated group compared with the control and the TBT + GTE groups
| T3 (ng/dl) | Control group (n = 15) | TBT treated group (n = 15) | TBT + GTE group (n = 15) | F | p |
|---|---|---|---|---|---|
| Min. – Max. | 79.0–108.0 | 39.0–49.0 | 53.0–60.0 | 351.426* | <0.001* |
| Mean ± SD. | 93.13 ± 8.22 | 43.13 ± 3.40 | 57.20 ± 2.46 | ||
| Median | 92.0 | 42.0 | 57.0 | ||
| Significance between groups | p1 < 0.001*, p2 < 0.001*, p3 < 0.001* | ||||
F: F test (ANOVA), Significance between groups was done using Post Hoc Test (LSD)
p1: p value for comparing between Control and TBT treated groups
p2: p value for comparing between Control and TBT + GTE groups
p3: p value for comparing between TBT treated and TBT + GTE groups
*: Statistically significant at p ≤ 0.05